Showing results (341-350 of 386) with videos related to

Sort By:
Pageof 39
Journal of Leukocyte Biology|March 24, 2005
Evaluation of normal and neoplastic human mast cells for expression of CD172a (SIRPalpha), CD47, and SHP-1Stefan Florian, Minoo Ghannadan, Matthias Mayerhofer, et al.
Human Gene Therapy|August 1, 2012
The human rhodopsin kinase promoter in an AAV5 vector confers rod- and cone-specific expression in the primate retinaShannon E Boye, John J Alexander, Sanford L Boye, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 7, 2018
BEST1 gene therapy corrects a diffuse retina-wide microdetachment modulated by light exposureKarina E Guziewicz, Artur V Cideciyan, William A Beltran, et al.
Investigative Ophthalmology & Visual Science|March 13, 2012
Tyrosine-mutant AAV8 delivery of human MERTK provides long-term retinal preservation in RCS ratsWen-Tao Deng, Astra Dinculescu, Qiuhong Li, et al.
Aging Cell|November 28, 2024
The Ercc1-/Δ mouse model of XFE progeroid syndrome undergoes accelerated retinal degenerationAkilavalli Narasimhan, Seok Hong Min, Laura L Johnson, et al.
Human Gene Therapy. Clinical Development|March 23, 2016
Safety and Biodistribution Evaluation in CNGB3-Deficient Mice of rAAV2tYF-PR1.7-hCNGB3, a Recombinant AAV Vector for Treatment of AchromatopsiaGuo-jie Ye, Ewa Budzynski, Peter Sonnentag, et al.
Human Gene Therapy. Clinical Development|March 23, 2016
Safety and Biodistribution Evaluation in Cynomolgus Macaques of rAAV2tYF-PR1.7-hCNGB3, a Recombinant AAV Vector for Treatment of AchromatopsiaGuo-jie Ye, Ewa Budzynski, Peter Sonnentag, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 22, 2018
Mutation-independent rhodopsin gene therapy by knockdown and replacement with a single AAV vectorArtur V Cideciyan, Raghavi Sudharsan, Valérie L Dufour, et al.
Gene Therapy|November 16, 2012
scAAV-mediated gene transfer of interleukin-1-receptor antagonist to synovium and articular cartilage in large mammalian jointsR S Watson, T A Broome, P P Levings, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 24, 2005
Identification of mTOR as a novel bifunctional target in chronic myeloid leukemia: dissection of growth-inhibitory and VEGF-suppressive effects of rapamycin in leukemic cellsMatthias Mayerhofer, Karl J Aichberger, Stefan Florian, et al.
Pageof 39